{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:22:14Z","timestamp":1791404534350,"version":"4.3.3"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1I1A3070388"],"award-info":[{"award-number":["NRF-2020R1I1A3070388"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1F1A1076616"],"award-info":[{"award-number":["NRF-2020R1F1A1076616"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1I1A3060435"],"award-info":[{"award-number":["NRF-2021R1I1A3060435"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chonnam National University Hospital Biomedical Research Institute","award":["BCRI23041"],"award-info":[{"award-number":["BCRI23041"]}]},{"name":"Chonnam National University Hospital Biomedical Research Institute","award":["BCRI25048"],"award-info":[{"award-number":["BCRI25048"]}]},{"DOI":"10.13039\/501100003661","name":"Korea Institute for Advancement of Technology","doi-asserted-by":"publisher","award":["P0020818"],"award-info":[{"award-number":["P0020818"]}],"id":[{"id":"10.13039\/501100003661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2020-KH088567"],"award-info":[{"award-number":["RS-2020-KH088567"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2020-KH106539"],"award-info":[{"award-number":["RS-2020-KH106539"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04306-5","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T18:24:08Z","timestamp":1745173448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Neural-induced human adipose tissue-derived stem cell secretome exerts neuroprotection against rotenone-induced Parkinson\u2019s disease in rats"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8831-4375","authenticated-orcid":false,"given":"Mahesh","family":"Ramalingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8673-7887","authenticated-orcid":false,"given":"Sujeong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0672-3601","authenticated-orcid":false,"given":"Jinsu","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1331-4039","authenticated-orcid":false,"given":"Hyong-Ho","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6827-6730","authenticated-orcid":false,"given":"Byeong C.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6921-6625","authenticated-orcid":false,"given":"Han-Seong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,20]]},"reference":[{"key":"4306_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in lewy bodies. Nature. 1997;388:839\u201340.","journal-title":"Nature"},{"key":"4306_CR2","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1038\/emboj.2012.170","volume":"31","author":"N Exner","year":"2012","unstructured":"Exner N, Lutz AK, Haass C, Winklhofer KF. Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences. EMBO J. 2012;31:3038\u201362.","journal-title":"EMBO J"},{"key":"4306_CR3","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1172\/JCI29178","volume":"116","author":"JM Savitt","year":"2006","unstructured":"Savitt JM, Dawson VL, Dawson TM. Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest. 2006;116:1744\u201354.","journal-title":"J Clin Invest"},{"key":"4306_CR4","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","volume":"1867","author":"S Mehra","year":"2019","unstructured":"Mehra S, Sahay S, Maji SK. alpha-Synuclein misfolding and aggregation: implications in Parkinson\u2019s disease pathogenesis. Biochim Biophys Acta Proteins Proteom. 2019;1867:890\u2013908.","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"4306_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","volume":"91","author":"M Yamada","year":"2004","unstructured":"Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H. Overexpression of alpha-synuclein in rat substantia Nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson\u2019s disease. J Neurochem. 2004;91:451\u201361.","journal-title":"J Neurochem"},{"key":"4306_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH. Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol Dis. 2018;109:249\u201357.","journal-title":"Neurobiol Dis"},{"key":"4306_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/325253a0","volume":"325","author":"RC Janzer","year":"1987","unstructured":"Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature. 1987;325:253\u20137.","journal-title":"Nature"},{"key":"4306_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.nbd.2009.10.006","volume":"37","author":"B Cameron","year":"2010","unstructured":"Cameron B, Landreth GE. Inflammation, microglia, and Alzheimer\u2019s disease. Neurobiol Dis. 2010;37:503\u20139.","journal-title":"Neurobiol Dis"},{"key":"4306_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia Nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38:1285\u201391.","journal-title":"Neurology"},{"key":"4306_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/jnr.21869","volume":"87","author":"H Takeuchi","year":"2009","unstructured":"Takeuchi H, Yanagida T, Inden M, Takata K, Kitamura Y, Yamakawa K, et al. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson\u2019s disease models. J Neurosci Res. 2009;87:576\u201385.","journal-title":"J Neurosci Res"},{"key":"4306_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5607\/en.2012.21.3.123","volume":"21","author":"Y Tsuboi","year":"2012","unstructured":"Tsuboi Y. Environmental-genetic interactions in the pathogenesis of Parkinson\u2019s disease. Exp Neurobiol. 2012;21:123\u20138.","journal-title":"Exp Neurobiol"},{"key":"4306_CR12","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.jchemneu.2020.101890","volume":"112","author":"R Balakrishnan","year":"2021","unstructured":"Balakrishnan R, Vijayraja D, Mohankumar T, Manimaran D, Ganesan P, Choi DK, et al. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson\u2019s disease. J Chem Neuroanat. 2021;112:101890.","journal-title":"J Chem Neuroanat"},{"key":"4306_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT. A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol Dis. 2009;34:279\u201390.","journal-title":"Neurobiol Dis"},{"key":"4306_CR14","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci. 2000;3:1301\u20136.","journal-title":"Nat Neurosci"},{"key":"4306_CR15","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1471-4159.2006.04440.x","volume":"101","author":"M Inden","year":"2007","unstructured":"Inden M, Kitamura Y, Takeuchi H, Yanagida T, Takata K, Kobayashi Y, et al. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J Neurochem. 2007;101:1491\u2013504.","journal-title":"J Neurochem"},{"key":"4306_CR16","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4103\/1673-5374.194803","volume":"11","author":"SV Hegarty","year":"2016","unstructured":"Hegarty SV, Sullivan AM, O\u2019Keeffe GW. The epigenome as a therapeutic target for Parkinson\u2019s disease. Neural Regen Res. 2016;11:1735\u20138.","journal-title":"Neural Regen Res"},{"key":"4306_CR17","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1007\/s00018-013-1290-8","volume":"70","author":"FG Teixeira","year":"2013","unstructured":"Teixeira FG, Carvalho MM, Sousa N, Salgado AJ. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol Life Sci. 2013;70:3871\u201382.","journal-title":"Cell Mol Life Sci"},{"key":"4306_CR18","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/stem.2636","volume":"35","author":"E Napoli","year":"2017","unstructured":"Napoli E, Borlongan CV. Cell therapy in Parkinson\u2019s disease: host brain repair machinery gets a boost from stem cell grafts. Stem Cells. 2017;35:1443\u20135.","journal-title":"Stem Cells"},{"key":"4306_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13287-022-03050-4","volume":"13","author":"RM Heris","year":"2022","unstructured":"Heris RM, Shirvaliloo M, Abbaspour-Aghdam S, Hazrati A, Shariati A, Youshanlouei HR, et al. The potential use of mesenchymal stem cells and their exosomes in Parkinson\u2019s disease treatment. Stem Cell Res Ther. 2022;13:371.","journal-title":"Stem Cell Res Ther"},{"key":"4306_CR20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.5966\/sctm.2016-0071","volume":"6","author":"FG Teixeira","year":"2017","unstructured":"Teixeira FG, Carvalho MM, Panchalingam KM, Rodrigues AJ, Mendes-Pinheiro B, Anjo S, et al. Impact of the secretome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of Parkinson\u2019s disease. Stem Cells Transl Med. 2017;6:634\u201346.","journal-title":"Stem Cells Transl Med"},{"key":"4306_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fbioe.2019.00294","volume":"7","author":"B Mendes-Pinheiro","year":"2019","unstructured":"Mendes-Pinheiro B, Anjo SI, Manadas B, Da Silva JD, Marote A, Behie LA, et al. Bone marrow mesenchymal stem cells\u2019 secretome exerts neuroprotective effects in a Parkinson\u2019s disease rat model. Front Bioeng Biotechnol. 2019;7:294.","journal-title":"Front Bioeng Biotechnol"},{"key":"4306_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/1673-5374.264455","volume":"15","author":"FG Teixeira","year":"2020","unstructured":"Teixeira FG, Salgado AJ. Mesenchymal stem cells secretome: current trends and future challenges. Neural Regen Res. 2020;15:75\u20137.","journal-title":"Neural Regen Res"},{"key":"4306_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","volume":"49","author":"I Wortzel","year":"2019","unstructured":"Wortzel I, Dror S, Kenific CM, Lyden D. Exosome-mediated metastasis: communication from a distance. Dev Cell. 2019;49:347\u201360.","journal-title":"Dev Cell"},{"key":"4306_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373\u201383.","journal-title":"J Cell Biol"},{"key":"4306_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fphys.2012.00228","volume":"3","author":"CP Lai","year":"2012","unstructured":"Lai CP, Breakefield XO. Role of exosomes\/microvesicles in the nervous system and use in emerging therapies. Front Physiol. 2012;3:228.","journal-title":"Front Physiol"},{"key":"4306_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fcell.2016.00083","volume":"4","author":"J Burrello","year":"2016","unstructured":"Burrello J, Monticone S, Gai C, Gomez Y, Kholia S, Camussi G. Stem Cell-Derived extracellular vesicles and Immune-Modulation. Front Cell Dev Biol. 2016;4:83.","journal-title":"Front Cell Dev Biol"},{"key":"4306_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/cells9020315","volume":"9","author":"FG Teixeira","year":"2020","unstructured":"Teixeira FG, Vilaca-Faria H, Domingues AV, Campos J, Salgado AJ. Preclinical comparison of stem cells secretome and Levodopa application in a 6-hydroxydopamine rat model of Parkinson\u2019s disease. Cells. 2020;9:315.","journal-title":"Cells"},{"key":"4306_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2121-11-25","volume":"11","author":"S Jang","year":"2010","unstructured":"Jang S, Cho HH, Cho YB, Park JS, Jeong HS. Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin. BMC Cell Biol. 2010;11:25.","journal-title":"BMC Cell Biol"},{"key":"4306_CR29","doi-asserted-by":"publisher","first-page":"178618","DOI":"10.1155\/2015\/178618","volume":"2015","author":"S Jang","year":"2015","unstructured":"Jang S, Park JS, Jeong HS. Neural differentiation of human adipose tissue-derived stem cells involves activation of the Wnt5a\/JNK signalling. Stem Cells Int. 2015;2015:178618.","journal-title":"Stem Cells Int"},{"key":"4306_CR30","doi-asserted-by":"publisher","first-page":"994","DOI":"10.4103\/1673-5374.184503","volume":"11","author":"S Jang","year":"2016","unstructured":"Jang S, Cho HH, Kim SH, Lee KH, Cho YB, Park JS, et al. Transplantation of human adipose tissue-derived stem cells for repair of injured spiral ganglion neurons in deaf Guinea pigs. Neural Regen Res. 2016;11:994\u20131000.","journal-title":"Neural Regen Res"},{"key":"4306_CR31","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.3390\/ijms22052322","volume":"22","author":"M Ramalingam","year":"2021","unstructured":"Ramalingam M, Jang S, Jeong HS. Neural-induced human adipose tissue-derived stem cells conditioned medium ameliorates rotenone-induced toxicity in SH-SY5Y cells. Int J Mol Sci. 2021;22:2322.","journal-title":"Int J Mol Sci"},{"key":"4306_CR32","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.3390\/ijms23084193","volume":"23","author":"M Ramalingam","year":"2022","unstructured":"Ramalingam M, Jeong HS, Hwang J, Cho HH, Kim BC, Kim E, et al. Autophagy signaling by neural-induced human adipose tissue-derived stem cell-conditioned medium during rotenone-induced toxicity in SH-SY5Y cells. Int J Mol Sci. 2022;23:4193.","journal-title":"Int J Mol Sci"},{"key":"4306_CR33","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.3390\/ijms24065622","volume":"24","author":"M Ramalingam","year":"2023","unstructured":"Ramalingam M, Jang S, Hwang J, Kim B, Cho HH, Kim E, et al. Neuroprotective effects of the neural-induced adipose-derived stem cell secretome against rotenone-induced mitochondrial and Endoplasmic reticulum dysfunction. Int J Mol Sci. 2023;24:5622.","journal-title":"Int J Mol Sci"},{"key":"4306_CR34","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.3390\/ijms25126362","volume":"25","author":"E Jang","year":"2024","unstructured":"Jang E, Yu H, Kim E, Hwang J, Yoo J, Choi J, et al. The therapeutic effects of blueberry-treated stem cell-derived extracellular vesicles in ischemic stroke. Int J Mol Sci. 2024;25:6362.","journal-title":"Int J Mol Sci"},{"key":"4306_CR35","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"2007","unstructured":"Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6 ed. New York: Academic; 2007.","edition":"6"},{"key":"4306_CR36","doi-asserted-by":"publisher","first-page":"6658271","DOI":"10.1155\/2021\/6658271","volume":"2021","author":"M Ramalingam","year":"2021","unstructured":"Ramalingam M, Jang S, Jeong HS. Therapeutic effects of conditioned medium of neural differentiated human bone marrow-derived stem cells on rotenone-induced alpha-synuclein aggregation and apoptosis. Stem Cells Int. 2021;2021:6658271.","journal-title":"Stem Cells Int"},{"key":"4306_CR37","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3389\/fnins.2019.01028","volume":"13","author":"M Ramalingam","year":"2019","unstructured":"Ramalingam M, Huh YJ, Lee YI. The impairments of alpha-synuclein and mechanistic target of Rapamycin in rotenone-induced SH-SY5Y cells and mice model of Parkinson\u2019s disease. Front Neurosci. 2019;13:1028.","journal-title":"Front Neurosci"},{"key":"4306_CR38","doi-asserted-by":"crossref","unstructured":"McGeer EG, McGeer PL. Some Characteristics of Brain Tyrosine Hydroxylase. In New Concepts in Neurotransmitter Regulation. Edited by Mandell AJ. Boston, MA: Springer US; 1973: 53\u201368.","DOI":"10.1007\/978-1-4613-4574-9_4"},{"key":"4306_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41531-022-00388-7","volume":"8","author":"HA Lashuel","year":"2022","unstructured":"Lashuel HA, Mahul-Mellier AL, Novello S, Hegde RN, Jasiqi Y, Altay MF, et al. Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity. NPJ Parkinsons Dis. 2022;8:136.","journal-title":"NPJ Parkinsons Dis"},{"key":"4306_CR40","first-page":"e61522","volume":"16","author":"T Mino","year":"2024","unstructured":"Mino T, Nakao S, Kitaura A, Iwamoto T, Kimura S, Nakajima Y, et al. Dexmedetomidine inhibits hippocampal neuronal damage caused by persistent isoflurane-induced hypotension in rat model of chronic cerebral hypoperfusion. Cureus. 2024;16:e61522.","journal-title":"Cureus"},{"key":"4306_CR41","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K, et al. Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun. 2020;11:1386.","journal-title":"Nat Commun"},{"key":"4306_CR42","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.3390\/cells9122623","volume":"9","author":"I Miyazaki","year":"2020","unstructured":"Miyazaki I, Asanuma M. Neuron-Astrocyte interactions in Parkinson\u2019s disease. Cells. 2020;9:2623.","journal-title":"Cells"},{"key":"4306_CR43","doi-asserted-by":"publisher","first-page":"102114","DOI":"10.1016\/j.pneurobio.2021.102114","volume":"204","author":"M Huang","year":"2021","unstructured":"Huang M, Chen S. DJ-1 in neurodegenerative diseases: pathogenesis and clinical application. Prog Neurobiol. 2021;204:102114.","journal-title":"Prog Neurobiol"},{"key":"4306_CR44","doi-asserted-by":"crossref","first-page":"342ra378","DOI":"10.1126\/scitranslmed.aaf3634","volume":"8","author":"R Di Maio","year":"2016","unstructured":"Di Maio R, Barrett PJ, Hoffman EK, Barrett CW, Zharikov A, Borah A, et al. alpha-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease. Sci Transl Med. 2016;8:342ra378.","journal-title":"Sci Transl Med"},{"key":"4306_CR45","doi-asserted-by":"publisher","first-page":"21742","DOI":"10.1074\/jbc.M113.451815","volume":"288","author":"I Prots","year":"2013","unstructured":"Prots I, Veber V, Brey S, Campioni S, Buder K, Riek R, et al. \u03b1-Synuclein oligomers impair neuronal microtubule-kinesin interplay. J Biol Chem. 2013;288:21742\u201354.","journal-title":"J Biol Chem"},{"key":"4306_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6603(08)60823-5","volume":"61","author":"JP Julien","year":"1998","unstructured":"Julien JP, Mushynski WE. Neurofilaments in health and disease. Prog Nucleic Acid Res Mol Biol. 1998;61:1\u201323.","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"4306_CR47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fnins.2018.00431","volume":"12","author":"H Ding","year":"2018","unstructured":"Ding H, Xiong Y, Sun J, Chen C, Gao J, Xu H. Asiatic acid prevents oxidative stress and apoptosis by inhibiting the translocation of alpha-synuclein into mitochondria. Front Neurosci. 2018;12:431.","journal-title":"Front Neurosci"},{"key":"4306_CR48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.canlet.2008.05.045","volume":"273","author":"J Luo","year":"2009","unstructured":"Luo J. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett. 2009;273:194\u2013200.","journal-title":"Cancer Lett"},{"key":"4306_CR49","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/cdd.2010.191","volume":"18","author":"R Kang","year":"2011","unstructured":"Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18:571\u201380.","journal-title":"Cell Death Differ"},{"key":"4306_CR50","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/biom12040493","volume":"12","author":"JD Vavilova","year":"2022","unstructured":"Vavilova JD, Boyko AA, Troyanova NI, Ponomareva NV, Fokin VF, Fedotova EY, et al. Alterations in proteostasis system components in peripheral blood mononuclear cells in Parkinson disease: focusing on the HSP70 and p62 levels. Biomolecules. 2022;12:493.","journal-title":"Biomolecules"},{"key":"4306_CR51","doi-asserted-by":"publisher","first-page":"174136","DOI":"10.1016\/j.ejphar.2021.174136","volume":"903","author":"M Aimaiti","year":"2021","unstructured":"Aimaiti M, Wumaier A, Aisa Y, Zhang Y, Xirepu X, Aibaidula Y, et al. Acteoside exerts neuroprotection effects in the model of Parkinson\u2019s disease via inducing autophagy: network Pharmacology and experimental study. Eur J Pharmacol. 2021;903:174136.","journal-title":"Eur J Pharmacol"},{"key":"4306_CR52","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1046\/j.1471-4159.2002.01190.x","volume":"83","author":"PJ McLean","year":"2002","unstructured":"McLean PJ, Kawamata H, Shariff S, Hewett J, Sharma N, Ueda K, et al. TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation. J Neurochem. 2002;83:846\u201354.","journal-title":"J Neurochem"},{"key":"4306_CR53","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/mt.2012.28","volume":"20","author":"MS Gorbatyuk","year":"2012","unstructured":"Gorbatyuk MS, Shabashvili A, Chen W, Meyers C, Sullivan LF, Salganik M, et al. Glucose regulated protein 78 diminishes alpha-synuclein neurotoxicity in a rat model of Parkinson disease. Mol Ther. 2012;20:1327\u201337.","journal-title":"Mol Ther"},{"key":"4306_CR54","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3109\/10408444.2012.680431","volume":"42","author":"N Xiong","year":"2012","unstructured":"Xiong N, Long X, Xiong J, Jia M, Chen C, Huang J, et al. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson\u2019s disease models. Crit Rev Toxicol. 2012;42:613\u201332.","journal-title":"Crit Rev Toxicol"},{"key":"4306_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nbd.2009.06.017","volume":"36","author":"RE Drolet","year":"2009","unstructured":"Drolet RE, Cannon JR, Montero L, Greenamyre JT. Chronic rotenone exposure reproduces Parkinson\u2019s disease Gastrointestinal neuropathology. Neurobiol Dis. 2009;36:96\u2013102.","journal-title":"Neurobiol Dis"},{"key":"4306_CR56","doi-asserted-by":"publisher","first-page":"9191284","DOI":"10.1155\/2022\/9191284","volume":"2022","author":"W Liang","year":"2022","unstructured":"Liang W, Yao L, Chen J, Chen Z, Wu X, Huang X. Therapeutic and neuroprotective effects of Bushen Jianpi Decoction on a rotenone-induced rat model of Parkinson\u2019s disease. Evid Based Complement Alternat Med. 2022;2022:9191284.","journal-title":"Evid Based Complement Alternat Med"},{"key":"4306_CR57","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1016\/S0021-9258(18)93832-9","volume":"239","author":"T Nagatsu","year":"1964","unstructured":"Nagatsu T, Levitt M, Udenfriend S. Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem. 1964;239:2910\u20137.","journal-title":"J Biol Chem"},{"key":"4306_CR58","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410270405","volume":"27","author":"GM Halliday","year":"1990","unstructured":"Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RG, Howe PR, et al. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson\u2019s disease. Ann Neurol. 1990;27:373\u201385.","journal-title":"Ann Neurol"},{"key":"4306_CR59","doi-asserted-by":"publisher","first-page":"e0162696","DOI":"10.1371\/journal.pone.0162696","volume":"11","author":"J Yuan","year":"2016","unstructured":"Yuan J, Ren J, Wang Y, He X, Zhao Y. Acteoside binds to caspase-3 and exerts neuroprotection in the rotenone rat model of Parkinson\u2019s disease. PLoS ONE. 2016;11:e0162696.","journal-title":"PLoS ONE"},{"key":"4306_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E. The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci. 2013;14:38\u201348.","journal-title":"Nat Rev Neurosci"},{"key":"4306_CR61","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","volume":"75","author":"T Tokuda","year":"2010","unstructured":"Tokuda T, Qureshi MM, Ardah MT, Varghese S, Shehab SA, Kasai T, et al. Detection of elevated levels of alpha-synuclein oligomers in CSF from patients with Parkinson disease. Neurology. 2010;75:1766\u201372.","journal-title":"Neurology"},{"key":"4306_CR62","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","volume":"240","author":"DG Walker","year":"2013","unstructured":"Walker DG, Lue LF, Adler CH, Shill HA, Caviness JN, Sabbagh MN, et al. Changes in properties of Serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains. Exp Neurol. 2013;240:190\u2013204.","journal-title":"Exp Neurol"},{"key":"4306_CR63","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"JL Guo","year":"2014","unstructured":"Guo JL, Lee VM. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med. 2014;20:130\u20138.","journal-title":"Nat Med"},{"key":"4306_CR64","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O\u2019Sullivan GA, Pal A, et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep. 2012;2:898.","journal-title":"Sci Rep"},{"key":"4306_CR65","doi-asserted-by":"publisher","first-page":"949","DOI":"10.5966\/sctm.2016-0111","volume":"6","author":"SH Oh","year":"2017","unstructured":"Oh SH, Kim HN, Park HJ, Shin JY, Kim DY, Lee PH. The cleavage effect of mesenchymal stem cell and its derived matrix metalloproteinase-2 on extracellular alpha-synuclein aggregates in parkinsonian models. Stem Cells Transl Med. 2017;6:949\u201361.","journal-title":"Stem Cells Transl Med"},{"key":"4306_CR66","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"4306_CR67","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3233\/JAD-200608","volume":"77","author":"A Benussi","year":"2020","unstructured":"Benussi A, Ashton NJ, Karikari TK, Gazzina S, Premi E, Benussi L, et al. Serum glial fibrillary acidic protein (GFAP) is a marker of disease severity in frontotemporal Lobar degeneration. J Alzheimers Dis. 2020;77:1129\u201341.","journal-title":"J Alzheimers Dis"},{"key":"4306_CR68","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.neuint.2013.01.007","volume":"62","author":"KS Madathil","year":"2013","unstructured":"Madathil KS, Karuppagounder SS, Haobam R, Varghese M, Rajamma U, Mohanakumar KP. Nitric oxide synthase inhibitors protect against rotenone-induced, oxidative stress mediated parkinsonism in rats. Neurochem Int. 2013;62:674\u201383.","journal-title":"Neurochem Int"},{"key":"4306_CR69","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","volume":"79","author":"SA Wolf","year":"2017","unstructured":"Wolf SA, Boddeke HW, Kettenmann H. Microglia in physiology and disease. Annu Rev Physiol. 2017;79:619\u201343.","journal-title":"Annu Rev Physiol"},{"key":"4306_CR70","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.23455","volume":"26","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Stevens CH. Glia: initiators and progressors of pathology in Parkinson\u2019s disease. Mov Disord. 2011;26:6\u201317.","journal-title":"Mov Disord"},{"key":"4306_CR71","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/brain\/awz104","volume":"142","author":"CW Olanow","year":"2019","unstructured":"Olanow CW, Savolainen M, Chu Y, Halliday GM, Kordower JH. Temporal evolution of microglia and alpha-synuclein accumulation following foetal grafting in Parkinson\u2019s disease. Brain. 2019;142:1690\u2013700.","journal-title":"Brain"},{"key":"4306_CR72","doi-asserted-by":"publisher","first-page":"719807","DOI":"10.3389\/fimmu.2021.719807","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L, et al. Targeting microglial alpha-synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s disease. Front Immunol. 2021;12:719807.","journal-title":"Front Immunol"},{"key":"4306_CR73","doi-asserted-by":"publisher","first-page":"683920","DOI":"10.1155\/2013\/683920","volume":"2013","author":"H Ariga","year":"2013","unstructured":"Ariga H, Takahashi-Niki K, Kato I, Maita H, Niki T, Iguchi-Ariga SM. Neuroprotective function of DJ-1 in Parkinson\u2019s disease. Oxid Med Cell Longev. 2013;2013:683920.","journal-title":"Oxid Med Cell Longev"},{"key":"4306_CR74","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1096\/fj.08-125153","volume":"23","author":"J Waak","year":"2009","unstructured":"Waak J, Weber SS, Waldenmaier A, Gorner K, Alunni-Fabbroni M, Schell H, et al. Regulation of astrocyte inflammatory responses by the Parkinson\u2019s disease-associated gene DJ-1. FASEB J. 2009;23:2478\u201389.","journal-title":"FASEB J"},{"key":"4306_CR75","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/ana.10782","volume":"55","author":"P Rizzu","year":"2004","unstructured":"Rizzu P, Hinkle DA, Zhukareva V, Bonifati V, Severijnen LA, Martinez D, et al. DJ-1 colocalizes with Tau inclusions: a link between parkinsonism and dementia. Ann Neurol. 2004;55:113\u20138.","journal-title":"Ann Neurol"},{"key":"4306_CR76","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1021\/acs.biochem.3c00028","volume":"62","author":"Q Gao","year":"2023","unstructured":"Gao Q, Jacob-Dolan JW, Scheck RA. Parkinsonism-associated protein DJ-1 is an antagonist, not an eraser, for protein glycation. Biochemistry. 2023;62:1181\u201390.","journal-title":"Biochemistry"},{"key":"4306_CR77","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1038\/emboj.2010.223","volume":"29","author":"F Kamp","year":"2010","unstructured":"Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, Brunner B, et al. Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, parkin and DJ-1. EMBO J. 2010;29:3571\u201389.","journal-title":"EMBO J"},{"key":"4306_CR78","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.exger.2017.01.001","volume":"89","author":"JH Koo","year":"2017","unstructured":"Koo JH, Cho JY, Lee UB. Treadmill exercise alleviates motor deficits and improves mitochondrial import machinery in an MPTP-induced mouse model of Parkinson\u2019s disease. Exp Gerontol. 2017;89:20\u20139.","journal-title":"Exp Gerontol"},{"key":"4306_CR79","doi-asserted-by":"publisher","first-page":"34105","DOI":"10.1074\/jbc.M503483200","volume":"280","author":"Y Ren","year":"2005","unstructured":"Ren Y, Liu W, Jiang H, Jiang Q, Feng J. Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J Biol Chem. 2005;280:34105\u201312.","journal-title":"J Biol Chem"},{"key":"4306_CR80","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.2174\/1381612825666191210154535","volume":"25","author":"Y Lee","year":"2020","unstructured":"Lee Y, Lee BH, Yip W, Chou P, Yip BS. Neurofilament proteins as prognostic biomarkers in neurological disorders. Curr Pharm Des. 2020;25:4560\u20139.","journal-title":"Curr Pharm Des"},{"key":"4306_CR81","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","volume":"88","author":"O Hansson","year":"2017","unstructured":"Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, et al. Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder. Neurology. 2017;88:930\u20137.","journal-title":"Neurology"},{"key":"4306_CR82","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0022-1759(03)00189-3","volume":"278","author":"A Petzold","year":"2003","unstructured":"Petzold A, Keir G, Green AJ, Giovannoni G, Thompson EJ. A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods. 2003;278:179\u201390.","journal-title":"J Immunol Methods"},{"key":"4306_CR83","doi-asserted-by":"publisher","first-page":"42","DOI":"10.32607\/20758251-2015-7-2-42-47","volume":"7","author":"VV Gusel\u2019nikova","year":"2015","unstructured":"Gusel\u2019nikova VV, Korzhevskiy DE. NeuN as a neuronal nuclear antigen and neuron differentiation marker. Acta Naturae. 2015;7:42\u20137.","journal-title":"Acta Naturae"},{"key":"4306_CR84","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1177\/44.10.8813082","volume":"44","author":"HK Wolf","year":"1996","unstructured":"Wolf HK, Buslei R, Schmidt-Kastner R, Schmidt-Kastner PK, Pietsch T, Wiestler OD, et al. NeuN: a useful neuronal marker for diagnostic histopathology. J Histochem Cytochem. 1996;44:1167\u201371.","journal-title":"J Histochem Cytochem"},{"key":"4306_CR85","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/01.MP.0000067422.61241.64","volume":"16","author":"M Hisaoka","year":"2003","unstructured":"Hisaoka M, Okamoto S, Koyama S, Ishida T, Imamura T, Kanda H, et al. Microtubule-associated protein-2 and class III beta-tubulin are expressed in extraskeletal myxoid chondrosarcoma. Mod Pathol. 2003;16:453\u20139.","journal-title":"Mod Pathol"},{"key":"4306_CR86","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/00005072-200606000-00007","volume":"65","author":"SE Counts","year":"2006","unstructured":"Counts SE, Nadeem M, Lad SP, Wuu J, Mufson EJ. Differential expression of synaptic proteins in the frontal and Temporal cortex of elderly subjects with mild cognitive impairment. J Neuropathol Exp Neurol. 2006;65:592\u2013601.","journal-title":"J Neuropathol Exp Neurol"},{"key":"4306_CR87","doi-asserted-by":"publisher","first-page":"509","DOI":"10.55782\/ane-2008-1717","volume":"68","author":"SJ Lee","year":"2008","unstructured":"Lee SJ, Jeon H, Kandror KV. Alpha-synuclein is localized in a subpopulation of rat brain synaptic vesicles. Acta Neurobiol Exp (Wars). 2008;68:509\u201315.","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"4306_CR88","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/brain\/awu057","volume":"137","author":"E Rockenstein","year":"2014","unstructured":"Rockenstein E, Nuber S, Overk CR, Ubhi K, Mante M, Patrick C, et al. Accumulation of oligomer-prone alpha-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain. 2014;137:1496\u2013513.","journal-title":"Brain"},{"key":"4306_CR89","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-5956-12-20","volume":"12","author":"HR Fuller","year":"2014","unstructured":"Fuller HR, Hurtado ML, Wishart TM, Gates MA. The rat striatum responds to nigro-striatal degeneration via the increased expression of proteins associated with growth and regeneration of neuronal circuitry. Proteome Sci. 2014;12:20.","journal-title":"Proteome Sci"},{"key":"4306_CR90","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1038\/srep01837","volume":"3","author":"D Cartelli","year":"2013","unstructured":"Cartelli D, Casagrande F, Busceti CL, Bucci D, Molinaro G, Traficante A, et al. Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective. Sci Rep. 2013;3:1837.","journal-title":"Sci Rep"},{"key":"4306_CR91","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2353\/ajpath.2009.080503","volume":"174","author":"K Nakayama","year":"2009","unstructured":"Nakayama K, Suzuki Y, Yazawa I. Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy. Am J Pathol. 2009;174:1471\u201380.","journal-title":"Am J Pathol"},{"key":"4306_CR92","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainresbull.2003.08.005","volume":"62","author":"JM Horowitz","year":"2003","unstructured":"Horowitz JM, Pastor DM, Goyal A, Kar S, Ramdeen N, Hallas BH, et al. BAX protein-immunoreactivity in midbrain neurons of Parkinson\u2019s disease patients. Brain Res Bull. 2003;62:55\u201361.","journal-title":"Brain Res Bull"},{"key":"4306_CR93","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1096\/fj.10-164624","volume":"25","author":"KM Danzer","year":"2011","unstructured":"Danzer KM, Ruf WP, Putcha P, Joyner D, Hashimoto T, Glabe C, et al. Heat-shock protein 70 modulates toxic extracellular alpha-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J. 2011;25:326\u201336.","journal-title":"FASEB J"},{"key":"4306_CR94","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-018-0273-5","volume":"13","author":"J Obergasteiger","year":"2018","unstructured":"Obergasteiger J, Frapporti G, Pramstaller PP, Hicks AA, Volta M. A new hypothesis for Parkinson\u2019s disease pathogenesis: GTPase-p38 MAPK signaling and autophagy as convergence points of etiology and genomics. Mol Neurodegener. 2018;13:40.","journal-title":"Mol Neurodegener"},{"key":"4306_CR95","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/ijms19102973","volume":"19","author":"A Bohush","year":"2018","unstructured":"Bohush A, Niewiadomska G, Filipek A. Role of mitogen activated protein kinase signaling in Parkinson\u2019s disease. Int J Mol Sci. 2018;19:2973.","journal-title":"Int J Mol Sci"},{"key":"4306_CR96","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.conb.2004.04.001","volume":"14","author":"JD Sweatt","year":"2004","unstructured":"Sweatt JD. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol. 2004;14:311\u20137.","journal-title":"Curr Opin Neurobiol"},{"key":"4306_CR97","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12967-016-0796-x","volume":"14","author":"C Palumbo","year":"2016","unstructured":"Palumbo C, De Luca A, Rosato N, Forgione M, Rotili D, Caccuri AM. c-Jun N-terminal kinase activation by nitrobenzoxadiazoles leads to late-stage autophagy Inhibition. J Transl Med. 2016;14:37.","journal-title":"J Transl Med"},{"key":"4306_CR98","doi-asserted-by":"publisher","first-page":"570586","DOI":"10.3389\/fnmol.2020.570586","volume":"13","author":"PR Asih","year":"2020","unstructured":"Asih PR, Prikas E, Stefanoska K, Tan ARP, Ahel HI, Ittner A. Functions of p38 MAP kinases in the central nervous system. Front Mol Neurosci. 2020;13:570586.","journal-title":"Front Mol Neurosci"},{"key":"4306_CR99","doi-asserted-by":"publisher","first-page":"e0139914","DOI":"10.1371\/journal.pone.0139914","volume":"10","author":"RK Brobey","year":"2015","unstructured":"Brobey RK, German D, Sonsalla PK, Gurnani P, Pastor J, Hsieh CC, et al. Klotho protects dopaminergic neuron oxidant-induced degeneration by modulating ASK1 and p38 MAPK signaling pathways. PLoS ONE. 2015;10:e0139914.","journal-title":"PLoS ONE"},{"key":"4306_CR100","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.brainres.2011.01.056","volume":"1382","author":"A Kosakai","year":"2011","unstructured":"Kosakai A, Ito D, Nihei Y, Yamashita S, Okada Y, Takahashi K, et al. Degeneration of mesencephalic dopaminergic neurons in Klotho mouse related to vitamin D exposure. Brain Res. 2011;1382:109\u201317.","journal-title":"Brain Res"},{"key":"4306_CR101","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neulet.2008.03.026","volume":"436","author":"G Xiromerisiou","year":"2008","unstructured":"Xiromerisiou G, Hadjigeorgiou GM, Papadimitriou A, Katsarogiannis E, Gourbali V, Singleton AB. Association between AKT1 gene and Parkinson\u2019s disease: a protective haplotype. Neurosci Lett. 2008;436:232\u20134.","journal-title":"Neurosci Lett"},{"key":"4306_CR102","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF03033861","volume":"14","author":"TD King","year":"2008","unstructured":"King TD, Clodfelder-Miller B, Barksdale KA, Bijur GN. Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency. Neurotox Res. 2008;14:367\u201382.","journal-title":"Neurotox Res"},{"key":"4306_CR103","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3892\/mmr.2014.2080","volume":"9","author":"DW Li","year":"2014","unstructured":"Li DW, Liu ZQ, Chen W, Yao M, Li GR. Association of glycogen synthase kinase-3beta with Parkinson\u2019s disease. Mol Med Rep. 2014;9:2043\u201350.","journal-title":"Mol Med Rep"},{"key":"4306_CR104","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neulet.2008.10.104","volume":"449","author":"M Nagao","year":"2009","unstructured":"Nagao M, Hayashi H. Glycogen synthase kinase-3beta is associated with Parkinson\u2019s disease. Neurosci Lett. 2009;449:103\u20137.","journal-title":"Neurosci Lett"},{"key":"4306_CR105","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.apsb.2019.10.003","volume":"10","author":"H Xiang","year":"2020","unstructured":"Xiang H, Zhang J, Lin C, Zhang L, Liu B, Ouyang L. Targeting autophagy-related protein kinases for potential therapeutic purpose. Acta Pharm Sin B. 2020;10:569\u201381.","journal-title":"Acta Pharm Sin B"},{"key":"4306_CR106","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/cdd.2014.179","volume":"22","author":"JJ Credle","year":"2015","unstructured":"Credle JJ, George JL, Wills J, Duka V, Shah K, Lee YC, et al. GSK-3beta dysregulation contributes to parkinson\u2019s-like pathophysiology with associated region-specific phosphorylation and accumulation of Tau and alpha-synuclein. Cell Death Differ. 2015;22:838\u201351.","journal-title":"Cell Death Differ"},{"key":"4306_CR107","doi-asserted-by":"publisher","first-page":"e17953","DOI":"10.1371\/journal.pone.0017953","volume":"6","author":"J Wills","year":"2011","unstructured":"Wills J, Credle J, Haggerty T, Lee JH, Oaks AW, Sidhu A. Tauopathic changes in the striatum of A53T alpha-synuclein mutant mouse model of Parkinson\u2019s disease. PLoS ONE. 2011;6:e17953.","journal-title":"PLoS ONE"},{"key":"4306_CR108","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4161\/auto.6260","volume":"4","author":"B Levine","year":"2008","unstructured":"Levine B, Sinha S, Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy. 2008;4:600\u20136.","journal-title":"Autophagy"},{"key":"4306_CR109","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.biocel.2013.02.007","volume":"45","author":"LL Fu","year":"2013","unstructured":"Fu LL, Cheng Y, Liu B. Beclin-1: autophagic regulator and therapeutic target in cancer. Int J Biochem Cell Biol. 2013;45:921\u20134.","journal-title":"Int J Biochem Cell Biol"},{"key":"4306_CR110","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pneurobio.2013.10.004","volume":"112","author":"S Ghavami","year":"2014","unstructured":"Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112:24\u201349.","journal-title":"Prog Neurobiol"},{"key":"4306_CR111","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0002-9440(10)64369-6","volume":"160","author":"K Zatloukal","year":"2002","unstructured":"Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, et al. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol. 2002;160:255\u201363.","journal-title":"Am J Pathol"},{"key":"4306_CR112","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.neuroscience.2014.11.004","volume":"284","author":"F Wu","year":"2015","unstructured":"Wu F, Xu HD, Guan JJ, Hou YS, Gu JH, Zhen XC, et al. Rotenone impairs autophagic flux and lysosomal functions in Parkinson\u2019s disease. Neuroscience. 2015;284:900\u201311.","journal-title":"Neuroscience"},{"key":"4306_CR113","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.nbd.2011.05.022","volume":"43","author":"K Tanji","year":"2011","unstructured":"Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K. Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in lewy body disease. Neurobiol Dis. 2011;43:690\u20137.","journal-title":"Neurobiol Dis"},{"key":"4306_CR114","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.7150\/ijbs.43825","volume":"16","author":"SY Wang","year":"2020","unstructured":"Wang SY, Ni X, Hu KQ, Meng FL, Li M, Ma XL, et al. Cilostazol alleviate nicotine induced cardiomyocytes hypertrophy through modulation of autophagy by CTSB\/ROS\/p38MAPK\/JNK feedback loop. Int J Biol Sci. 2020;16:2001\u201313.","journal-title":"Int J Biol Sci"},{"key":"4306_CR115","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jmb.2012.06.034","volume":"423","author":"H Gao","year":"2012","unstructured":"Gao H, Yang W, Qi Z, Lu L, Duan C, Zhao C, et al. DJ-1 protects dopaminergic neurons against rotenone-induced apoptosis by enhancing ERK-dependent mitophagy. J Mol Biol. 2012;423:232\u201348.","journal-title":"J Mol Biol"},{"key":"4306_CR116","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1093\/hmg\/ddq288","volume":"19","author":"I Irrcher","year":"2010","unstructured":"Irrcher I, Aleyasin H, Seifert EL, Hewitt SJ, Chhabra S, Phillips M, et al. Loss of the Parkinson\u2019s disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet. 2010;19:3734\u201346.","journal-title":"Hum Mol Genet"},{"key":"4306_CR117","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jsb.2012.05.002","volume":"179","author":"J Winkler","year":"2012","unstructured":"Winkler J, Tyedmers J, Bukau B, Mogk A. Chaperone networks in protein disaggregation and prion propagation. J Struct Biol. 2012;179:152\u201360.","journal-title":"J Struct Biol"},{"key":"4306_CR118","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/cdd.2008.81","volume":"15","author":"J Li","year":"2008","unstructured":"Li J, Ni M, Lee B, Barron E, Hinton DR, Lee AS. The unfolded protein response regulator GRP78\/BiP is required for Endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells. Cell Death Differ. 2008;15:1460\u201371.","journal-title":"Cell Death Differ"},{"key":"4306_CR119","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012;13:89\u2013102.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4306_CR120","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1471-4159.2010.07143.x","volume":"116","author":"A Bellucci","year":"2011","unstructured":"Bellucci A, Navarria L, Zaltieri M, Falarti E, Bodei S, Sigala S, et al. Induction of the unfolded protein response by alpha-synuclein in experimental models of Parkinson\u2019s disease. J Neurochem. 2011;116:588\u2013605.","journal-title":"J Neurochem"},{"key":"4306_CR121","doi-asserted-by":"publisher","first-page":"113315","DOI":"10.1016\/j.fct.2022.113315","volume":"167","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Y, Sun X, Shi X, Xu S. Microplastics and Di (2-ethylhexyl) phthalate synergistically induce apoptosis in mouse pancreas through the GRP78\/CHOP\/Bcl-2 pathway activated by oxidative stress. Food Chem Toxicol. 2022;167:113315.","journal-title":"Food Chem Toxicol"},{"key":"4306_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1391.018","volume":"1113","author":"KA Morano","year":"2007","unstructured":"Morano KA. New tricks for an old dog: the evolving world of Hsp70. Ann N Y Acad Sci. 2007;1113:1\u201314.","journal-title":"Ann N Y Acad Sci"},{"key":"4306_CR123","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jmb.2006.08.062","volume":"364","author":"C Huang","year":"2006","unstructured":"Huang C, Cheng H, Hao S, Zhou H, Zhang X, Gao J, et al. Heat shock protein 70 inhibits alpha-synuclein fibril formation via interactions with diverse intermediates. J Mol Biol. 2006;364:323\u201336.","journal-title":"J Mol Biol"},{"key":"4306_CR124","doi-asserted-by":"publisher","first-page":"43150","DOI":"10.1074\/jbc.M507124200","volume":"280","author":"W Zhou","year":"2005","unstructured":"Zhou W, Freed CR. DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J Biol Chem. 2005;280:43150\u20138.","journal-title":"J Biol Chem"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04306-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04306-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04306-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T20:01:49Z","timestamp":1745179309000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04306-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,20]]},"references-count":124,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4306"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04306-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,20]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Adipose tissues from human donors were collected in accordance with the guidelines approved by the Chonnam National University Hospital Biomedical Research Ethics Review Committee and that informed consent was obtained from the donors (title: Establishment of cell resources and specific therapeutic techniques for nervous system diseases using human mesenchymal stem cells, committee: Chonnam National University Hospital Institutional Review Board, approval number: CNUH IRB-I-2009-03-016, date of approval: 25 March 2009, expiration date: 2 September 2025). All animal experimental procedures were conducted in accordance with the ARRIVE guidelines and approved by the Animal Experiment Ethics Committee of the Chonnam National University Medical and Life Science Convergence Center (title: Stem Cell-derived New Drug Development, committee: Chonnam National University Institutional Animal Care and Use Committee, approval number: CNU IACUC-H-2022-36, date of approval: 4 May 2022, period: 8 May 2022 ~ 7 May 2023; title: Stem Cell-derived New Drug Development, committee: Chonnam National University Institutional Animal Care and Use Committee, approval number: CNU IACUC-H-2023-11, date of approval: 19 April 2023, period: 20 April 2023 ~ 19 April 2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"193"}}